Intetumumab Antibody
Intetumumab (CNTO 95) is a fully human monoclonal antibody targeting α (v) -integrins. It acts as a radiosensitizer and demonstrates anti-tumor and anti-metastatic activity, as shown in A549 non-small cell lung cancer xenograft models. This makes it a valuable research tool for studying angiogenesis, metastasis, and combination therapies in oncology.
Product Specifications
Product Name Alternative
EGFR, Anti-Human CD51 Recombinant Antibody, CNTO 095, CNTO 95, CNTO095, CNTO95
Target
Integrin, EGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
5.09 mg/mL
Purity
97.10% (May vary between batches)
Molecular Weight
145.56 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Plgrkt (NM_001106347) Rat Tagged ORF Clone Lentiviral Particle
Primary Canine Pulmonary Fibroblasts (PF)